These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8512657)

  • 1. Long-term effects of the angiotensin converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus.
    Alkharouf J; Nalinikumari K; Corry D; Tuck M
    Am J Hypertens; 1993 May; 6(5 Pt 1):337-43. PubMed ID: 8512657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
    Yin W; Seghieri G; Boni C; Sanna G; Anichini R; Bartolomei G; Ferrannini E
    Chin Med Sci J; 1994 Mar; 9(1):29-33. PubMed ID: 8086631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
    Seghieri G; Yin W; Boni C; Sanna G; Anichini R; Bartolomei G; Ferrannini E
    Diabet Med; 1992 Oct; 9(8):732-8. PubMed ID: 1395466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
    Liou HH; Huang TP; Campese VM
    Nephron; 1995; 69(1):41-8. PubMed ID: 7891796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
    Guasch A; Parham M; Zayas CF; Campbell O; Nzerue C; Macon E
    J Am Soc Nephrol; 1997 May; 8(5):793-8. PubMed ID: 9176849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term comparison between enalapril and captopril on insulin sensitivity in normotensive non-insulin dependent diabetic volunteers.
    Tillmann HC; Walker RJ; Lewis-Barned NJ; Edwards EA; Robertson MC
    J Clin Pharm Ther; 1997 Aug; 22(4):273-8. PubMed ID: 9548208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients.
    Romero R; Salinas I; Lucas A; Teixidó J; Audi L; Sanmarti A
    Diabetes Res Clin Pract; 1992 Sep; 17(3):191-8. PubMed ID: 1425158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH; Nagalla S; Ballas SK
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an angiotensin converting enzyme inhibitor on skin microvascular hyperaemia in microalbuminuric insulin-dependent diabetes mellitus.
    Yosipovitch G; Schneiderman J; Erman A; Chetrit A; Milo G; Boner G; van Dijk DJ
    Diabet Med; 1997 Mar; 14(3):235-41. PubMed ID: 9088773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating catecholamines and metabolic effects of captopril in NIDDM patients.
    De Mattia G; Ferri C; Laurenti O; Cassone-Faldetta M; Piccoli A; Santucci A
    Diabetes Care; 1996 Mar; 19(3):226-30. PubMed ID: 8742566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
    Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
    Ottlecz A; Bensaoula T
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
    Santoro D; Natali A; Palombo C; Brandi LS; Piatti M; Ghione S; Ferrannini E
    Hypertension; 1992 Aug; 20(2):181-91. PubMed ID: 1639459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.